Rabies virus l protein b cell epitope polypeptides, monoclonal antibodies and uses
CN122213201APending Publication Date: 2026-06-16LONGHU LAB
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- LONGHU LAB
- Filing Date
- 2026-05-09
- Publication Date
- 2026-06-16
Smart Images

Figure CN122213201A_ABST
Abstract
The application discloses a rabies virus L protein B cell epitope polypeptide, a monoclonal antibody and application, and belongs to the technical field of biotechnology.A new type of B cell linear epitope of a rabies virus L protein is identified and disclosed for the first time, and the amino acid sequence is PLSRGEIFSIPQKIPA.The application further provides a monoclonal antibody against the rabies virus L protein, the monoclonal antibody can specifically recognize the B cell epitope, and provides an important tool for function research and expression detection of the rabies virus L protein.Meanwhile, the application determines key amino acid residues in the B cell epitope through an alanine scanning mutation technology, and provides a basis for in-depth understanding of an antigen-antibody interaction mechanism.In summary, the identified B cell epitope and the provided monoclonal antibody against the rabies virus L protein lay a solid technical foundation for development of a broad-spectrum rabies serological diagnostic reagent and a new type of vaccine (such as an epitope vaccine).
Need to check novelty before this filing date? Find Prior Art